Deutsche Bank’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $516K | Buy |
|
|||||
|
2025
Q2 | $451K | Sell |
|
|||||
|
2025
Q1 | $542K | Sell |
|
|||||
|
2024
Q4 | $687K | Buy |
|
|||||
|
2024
Q3 | $514K | Buy |
|
|||||
|
2024
Q2 | $356K | Buy |
|
|||||
|
2024
Q1 | $193K | Buy |
|
|||||
|
2023
Q4 | $147K | Sell |
|
|||||
|
2023
Q3 | $149K | Buy |
|
|||||
|
2023
Q2 | $190K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $0 | Sell |
|
|||||
|
2021
Q2 | $170K | Buy |
|
|||||
|
2021
Q1 | $96K | Buy |
|
|||||
|
2020
Q4 | $124K | Buy |
|
|||||
|
2020
Q3 | $56K | Buy |
|
|||||
|
2020
Q2 | $70K | Buy |
|